Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Minimal residual disease–guided therapy in childhood acute lymphoblastic leukemia

6 Feb 2017

Abstract excerpt

Case presentationsCase 1A 3-year-old boy presented with a leukocyte count of 5.9 3 10 9 /L and was found to have near-haploid B-lineage acute lymphoblastic leukemia (ALL) with a 27, X, 1Y, 113, 118, 121 karyotype.He was enrolled in the St. Jude Children's Research Hospital Total Therapy XV study.After 19 days of remission induction therapy with 1 high dose of methotrexate, 14 days of prednisone, 2 doses of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Acute Myeloid Leukemia Research
Share to Childhood Cancer Survivors' Quality of Life

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28167658
DOI: 10.1182/blood-2016-12-725804

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Minimal residual disease–guided therapy in childhood acute lymphoblastic leukemiaPMID 28167658Read ↗

Childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

Key Markers of Minimal Residual Disease in Childhood Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Detection and management of minimal residual disease in acute lymphoblastic leukemiaSemantic proximity Read ↗

Clinical Significance of Novel Subtypes of Acute Lymphoblastic Leukemia in the Context of Minimal Residual Disease–Directed TherapySemantic proximity Read ↗

Minimal Residual Disease Detection in Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Recent advances in the management of pediatric acute lymphoblastic leukemiaSemantic proximity Read ↗

Children’s Oncology Group Blueprint for Research: Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Childhood and adolescent lymphoid and myeloid leukemia.Semantic proximity Read ↗

Minimal residual disease: optimal methods, timing, and clinical relevance for an individual patientSemantic proximity Read ↗

Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologiesSemantic proximity Read ↗

Status of minimal residual disease testing in childhood haematological malignanciesSemantic proximity Read ↗

Significance of minimal residual disease in pediatric mixed phenotype acute leukemia: a multicenter cohort study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.